These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38421515)
1. Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022. Okizaki A; Nishiyama Y; Inui Y; Otsuka H; Takanami K; Nakajo M; Nakatani K; Nogami M; Hirata K; Maeda Y; Yoshimura M; Wakabayashi H Ann Nucl Med; 2024 Apr; 38(4):315-327. PubMed ID: 38421515 [TBL] [Abstract][Full Text] [Related]
2. Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017. Nishiyama Y; Kinuya S; Kato T; Kayano D; Sato S; Tashiro M; Tatsumi M; Hashimoto T; Baba S; Hirata K; Yoshimura M; Yoneyama H Ann Nucl Med; 2019 Oct; 33(10):725-732. PubMed ID: 31236776 [TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine practice in Japan: a report of the seventh nationwide survey in 2012. Kinuya S; Kuwabara Y; Inoue K; Sakamoto S; Shimosegawa E; Takeoka K; Takeda Y; Toyama H; Niio Y; Nishiyama Y; Yoshinaga K; Yoshimura M Ann Nucl Med; 2014 Dec; 28(10):1032-8. PubMed ID: 25113149 [TBL] [Abstract][Full Text] [Related]
4. Nuclear medicine practice in Japan: a report of the sixth nationwide survey in 2007. Kuwabara Y; Koizumi K; Ushijima Y; Kinuya S; Kinomura S; Suga K; Takeoka H; Takeda T; Toyama H; Arao Y; Nishiyama Y; Murakami K; Morita K Ann Nucl Med; 2009 Feb; 23(2):209-15. PubMed ID: 19225946 [TBL] [Abstract][Full Text] [Related]
5. Nuclear medicine practice in Japan: a report of the 5th nationwide survey in 2002. Koizumi K; Tamaki N; Inoue T; Kanaya S; Kuwabara Y; Kousaka T; Saiki Y; Saga T; Sone T; Taki J; Yamazaki T; ; ; Ann Nucl Med; 2004 Feb; 18(1):73-8. PubMed ID: 15072188 [TBL] [Abstract][Full Text] [Related]
6. The status of nuclear medicine in China: the first official national survey. Zhang H; Zheng J; Hu N; Liu Y; Yang G; Liu M; Jing H; Huo L Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2172-2178. PubMed ID: 38561514 [TBL] [Abstract][Full Text] [Related]
7. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong! Høilund-Carlsen PF Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853 [TBL] [Abstract][Full Text] [Related]
9. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990 [TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
11. Registry of nuclear medicine procedures in cardiology in Poland in 2019-2021. Teresińska A; Królicki L Nucl Med Rev Cent East Eur; 2023; 26(0):158-164. PubMed ID: 38153157 [TBL] [Abstract][Full Text] [Related]
12. Nationwide survey on radiation doses received by patients in nuclear medicine imaging procedures. Skovorodko K; Komiagienė R; Maciusovič M; Gilys L; Vajauskas D; Grigonienė V; Žiliukas J; Raudonienė J; Gricienė B J Radiol Prot; 2022 Aug; 42(3):. PubMed ID: 35850112 [TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours. Naji M; Zhao C; Welsh SJ; Meades R; Win Z; Ferrarese A; Tan T; Rubello D; Al-Nahhas A Mol Imaging Biol; 2011 Aug; 13(4):769-75. PubMed ID: 20700766 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. Ilias I; Chen CC; Carrasquillo JA; Whatley M; Ling A; Lazúrová I; Adams KT; Perera S; Pacak K J Nucl Med; 2008 Oct; 49(10):1613-9. PubMed ID: 18794260 [TBL] [Abstract][Full Text] [Related]
15. Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan. Watanabe H; Ishii K; Hosono M; Imabayashi E; Abe K; Inubushi M; Ohno K; Magata Y; Ono K; Kikuchi K; Wagatsuma K; Takase T; Saito K; Takahashi Y Ann Nucl Med; 2016 Jul; 30(6):435-44. PubMed ID: 27154308 [TBL] [Abstract][Full Text] [Related]
16. A Prospective Comparative Study of 18 F-FDOPA PET/CT Versus 123 I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma. Sung C; Lee HS; Lee DY; Kim YI; Kim JE; Lee SJ; Oh SJ; Sung TY; Lee YM; Kim YH; Kim BJ; Koh JM; Lee SH; Ryu JS Clin Nucl Med; 2024 Jan; 49(1):27-36. PubMed ID: 38054497 [TBL] [Abstract][Full Text] [Related]
18. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Taïeb D; Hicks RJ; Hindié E; Guillet BA; Avram A; Ghedini P; Timmers HJ; Scott AT; Elojeimy S; Rubello D; Virgolini IJ; Fanti S; Balogova S; Pandit-Taskar N; Pacak K Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2112-2137. PubMed ID: 31254038 [TBL] [Abstract][Full Text] [Related]
19. High-Specific-Activity- Jha A; Taïeb D; Carrasquillo JA; Pryma DA; Patel M; Millo C; de Herder WW; Del Rivero J; Crona J; Shulkin BL; Virgolini I; Chen AP; Mittal BR; Basu S; Dillon JS; Hope TA; Mari Aparici C; Iagaru AH; Hicks RJ; Avram AM; Strosberg JR; Civelek AC; Lin FI; Pandit-Taskar N; Pacak K Clin Cancer Res; 2021 Jun; 27(11):2989-2995. PubMed ID: 33685867 [TBL] [Abstract][Full Text] [Related]
20. Current Status of Nuclear Medicine Practice in the Middle East. Paez D; Becic T; Bhonsle U; Jalilian AR; Nuñez-Miller R; Osso JA Semin Nucl Med; 2016 Jul; 46(4):265-72. PubMed ID: 27237437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]